EADO 2022 | The management of squamous cell carcinoma

Antonio Tejera-Vaquerizo, MD, Instituto Dermatológico GlobalDerm, Córdoba, Spain, talks on the current approach to managing cutaneous squamous cell carcinoma, including complete clearance of the lesions, evaluation of high-risk characteristics and deciding whether the patient requires a sentinel lymph node biopsy. Thereafter, patients are evaluated on whether to receive radiotherapy, chemotherapy or immunotherapy. This interview took place at the EADO 2022 congress.